Hepatology

Cholestasis is seen in every 2,500–5,000 live births. In full-term infants, jaundice that lasts >2 weeks should be evaluated; however, it should be…

Primary sclerosing cholangitis (PSC) is a rare cholestatic disorder of the liver associated with inflammation and injury with fibrosis in the…

Despite the introduction of covered TIPSS, studies have not consistently demonstrated a survival benefit in secondary prevention…

One of the critical populations in this battle to achieve elimination is people who inject drugs (PWID), who in the UK represent 85% of the hepatitis C…

Clinical studies of the TPO-R agonist lusutrombopag included a large proportion of high-risk bleeding patients and therapy with this agent has been shown…

This review aims to give an overview and update our knowledge of AATD associated with liver disease and discusses possible new therapeutic strategies…

New imaging modalities are emerging and may potentially replace biopsy. This review discusses the different non-invasive imaging modalities…

The role of angiopoietin 2 (Ang-2) in HCV-related nephropathy and its relationship with platelet parameters and thrombopoietin (TPO) is evaluated in this…